Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to test the hypothesis that topical application of phenylephrine improves faecal continence and quality of life in subjects with passive faecal incontinence after ileo-anal pouch construction.


Clinical Trial Description

Faecal seepage and even frank incontinence at night can be a problem for approximately 30% of patients who have undergone ileal pouch anal anastomosis (IPAA). Nocturnal seepage may be a problem in patients who do not have gross incontinence, or who may even have no incontinence during the day. Although baseline continence during the day is maintained by involuntary control of the internal anal sphincter, this can be supplemented by voluntary contraction of the external sphincter. While sleeping, this supplementary external sphincter effect is lost and internal anal sphincter tone is reduced, leading to seepage. This is obviously distressing and leads some patients to wear a pad to reduce the soiling that may occur.

The primary objective is to determine the effect of 10% phenylephrine hydrochloride gel, applied three times a day, on the change from baseline to the end of study (8 weeks)in the faecal incontinence score (St Mark's) with passive faecal incontinence after ileo-anal pouch construction, compared with placebo. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00420797
Study type Interventional
Source S.L.A. Pharma AG
Contact
Status Withdrawn
Phase Phase 3
Start date February 2007
Completion date November 2007

See also
  Status Clinical Trial Phase
Recruiting NCT04918329 - Functional Digestive Disorders Observatory
Completed NCT02292628 - Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence Phase 1/Phase 2
Recruiting NCT04612569 - Feasibility and Impact of a Prehabilitation and Rehabilitation Program for the Continuity of Care in Severe Low Anterior Resection Syndrome.
Completed NCT05049486 - Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging N/A
Completed NCT02782364 - Evaluation of the Fast Fill Technique for Anal Acoustic Reflectometry (AAR) in the Incontinent Anal Sphincter
Withdrawn NCT03257332 - Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
Completed NCT03261622 - Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective N/A
Recruiting NCT03969069 - Assessment of Faecal Incontinence With MAPLe
Recruiting NCT05245565 - Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer
Completed NCT03078634 - The Multi-disciplinary Treatment of Functional Gut Disorders Study N/A
Recruiting NCT05900726 - Pelvipower for Faecal Incontinence N/A
Recruiting NCT05550675 - Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
Recruiting NCT04657588 - Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial N/A
Active, not recruiting NCT04262609 - Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Completed NCT05016453 - Long-term Efficacy of Percutaneous Tibial Nerve Stimulation Applied to Patients With Faecal Incontinence.
Completed NCT04007250 - FENIX™ Continence Restoration System Registry
Completed NCT02349334 - UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence Phase 3
Recruiting NCT06143072 - CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence
Recruiting NCT04276350 - Efficacy of Acupuncture as a Treatment for Faecal Incontinence N/A
Completed NCT01656720 - A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period Phase 2